Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Portier

Showing results (21-30 of 142) with videos related to

Pageof 15
Sort By:
La Nouvelle Presse Medicale|February 26, 1981
[Clinical experience of cefotaxime (author's transl)]H Portier, C Carbon, Y Boussougant, et al.
Infection|July 1, 1986
Vaccination against rabies with human diploid cell anti-rabies subcutaneous vaccination (HDVC)P Chavanet, H Portier, E Kamp, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 28, 2002
Sparfloxacin as alternative treatment to standard therapy for community-acquired bacteremic pneumococcal pneumoniaH. Lode, M. Aubier, H. Portier, et al.
Pathologie-Biologie|January 1, 1984
[Comparative value of complement fixation and indirect immunofluorescence reactions for the detection of Q fever]P Chavanet, A Pechinot, B Lobjoy, et al.
The New England Journal of Medicine|November 30, 1989
Perinatal pharmacokinetics of zidovudineP Chavanet, B Diquet, A Waldner, et al.
Lancet (London, England)|March 30, 1991
Imipenem/teicoplanin for Rhodococcus equi pulmonary infection in AIDS patientsP Chavanet, B Bonnotte, D Caillot, et al.
La Nouvelle Presse Medicale|April 21, 1979
[Human brucellosis. Treatment with combination of rifampicin and minocycline]H Portier, A Breuillot, A Kazmierczak, et al.
Lancet (London, England)|November 23, 1985
Intravenous gammaglobulin for adult Kawasaki diseaseP Chavanet, H Portier, F Escalier, et al.
Lancet (London, England)|August 2, 1980
Interaction between cephalosporins and alcoholH Portier, J M Chalopin, M Freysz, et al.
The Journal of Antimicrobial Chemotherapy|December 1, 1990
Five day treatment of pharyngotonsillitis with cefpodoxime proxetilH Portier, P Chavanet, J B Gouyon, et al.
Pageof 15

Showing results (21-30 of 142) with videos related to

Sort By:
Pageof 15
La Nouvelle Presse Medicale|February 26, 1981
[Clinical experience of cefotaxime (author's transl)]H Portier, C Carbon, Y Boussougant, et al.
Infection|July 1, 1986
Vaccination against rabies with human diploid cell anti-rabies subcutaneous vaccination (HDVC)P Chavanet, H Portier, E Kamp, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 28, 2002
Sparfloxacin as alternative treatment to standard therapy for community-acquired bacteremic pneumococcal pneumoniaH. Lode, M. Aubier, H. Portier, et al.
Pathologie-Biologie|January 1, 1984
[Comparative value of complement fixation and indirect immunofluorescence reactions for the detection of Q fever]P Chavanet, A Pechinot, B Lobjoy, et al.
The New England Journal of Medicine|November 30, 1989
Perinatal pharmacokinetics of zidovudineP Chavanet, B Diquet, A Waldner, et al.
Lancet (London, England)|March 30, 1991
Imipenem/teicoplanin for Rhodococcus equi pulmonary infection in AIDS patientsP Chavanet, B Bonnotte, D Caillot, et al.
La Nouvelle Presse Medicale|April 21, 1979
[Human brucellosis. Treatment with combination of rifampicin and minocycline]H Portier, A Breuillot, A Kazmierczak, et al.
Lancet (London, England)|November 23, 1985
Intravenous gammaglobulin for adult Kawasaki diseaseP Chavanet, H Portier, F Escalier, et al.
Lancet (London, England)|August 2, 1980
Interaction between cephalosporins and alcoholH Portier, J M Chalopin, M Freysz, et al.
The Journal of Antimicrobial Chemotherapy|December 1, 1990
Five day treatment of pharyngotonsillitis with cefpodoxime proxetilH Portier, P Chavanet, J B Gouyon, et al.
Pageof 15